Perfusion MRI grading diffuse gliomas: Impact of permeability parameters on molecular biomarkers and survival

被引:14
|
作者
Hilario, Amaya [1 ]
Hernandez-Lain, Aurelio [2 ]
Manuel Sepulveda, Juan [3 ]
Lagares, Alfonso [4 ]
Perez-Nunez, Angel [4 ]
Ramos, Ana [1 ]
机构
[1] Univ Hosp 12 Octubre, Neuroradiol Sect, Dept Radiol, Madrid, Spain
[2] Univ Hosp 12 Octubre, Dept Neuropathol, Madrid, Spain
[3] Univ Hosp 12 Octubre, Dept Med Oncol, Madrid, Spain
[4] Univ Hosp 12 Octubre, Dept Neurosurg, Madrid, Spain
来源
NEUROCIRUGIA | 2019年 / 30卷 / 01期
关键词
Brain; Glioma; Neoplasms; Perfusion; Permeability; CEREBRAL BLOOD-VOLUME; CONTRAST-ENHANCED MRI; TRANSFER-COEFFICIENT; MAGNETIC-RESONANCE; PROGNOSTIC VALUE; GLIOBLASTOMA; PREDICTION;
D O I
10.1016/j.neucir.2018.06.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background and purpose: Our objectives were: (1) compare dynamic susceptibility-weighted (DSC) and dynamic contrast-enhanced (DCE) permeability parameters, (2) evaluate diagnostic accuracy of DSC and DCE discriminating high- and low-grade tumors, (3) analyze relationship of permeability parameters with overall (OS) and progression-free survival (PFS) and (4) assess differences in high-grade tumors classified according to molecular biomarkers. Materials and methods: 49 patients with histologically proved diffuse gliomas underwent DSC and DCE imaging. Parametric maps of cerebral blood volume (CBV), CBV-leakage corrected, volume transfer coefficient (Ktrans), fractional volume of the extravascular extracellular space (EES) (Ve), fractional blood plasma volume (Vp) and rate constant between EES and blood plasma (Kep) were calculated. High-grade gliomas were also classified according to isocitrate dehydrogenase (IDH), alpha-thalassemia/mental retardation syndrome X-linked (ATRX) and 06-methylguanine-dna-methyltransferase promoter methylation (MGMT) status. Results: There is correlation between parameters leakage, Ktrans and Vp. ROC curve analysis showed significance in both Ktrans and Ve for glioma grading. Threshold value of 0.075 for Ve generated the best combination of sensitivity (80%) and specificity (75%) in tumor gradation. Leakage was the only permeability parameter related to OS (P = 0.006) and PFS 012); with prolonged survival for leakage values lower than 1.2. IDH-mutated high-grade tumors showed lower leakage and Ktrans values. High-grade tumors with loss of ATRX presented lower leakage and Vp values. Conclusions: Both DSC and DCE permeability parameters serve as non-invasive method for glioma grading. Leakage was the unique permeability parameter related to survival and the best discriminating high-grade gliomas classified according to IDH and ATRX status. (C) 2018 Sociedad Espanola de Neurocirugia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 50 条
  • [31] The impact of schizophrenia on frontal perfusion parameters: a DSC-MRI study
    Peruzzo, Denis
    Rambaldelli, Gianluca
    Bertoldo, Alessandra
    Bellani, Marcella
    Cerini, Roberto
    Silvia, Marini
    Mucelli, Roberto Pozzi
    Tansella, Michele
    Brambilla, Paolo
    JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (04) : 563 - 570
  • [32] The impact of schizophrenia on frontal perfusion parameters: a DSC-MRI study
    Denis Peruzzo
    Gianluca Rambaldelli
    Alessandra Bertoldo
    Marcella Bellani
    Roberto Cerini
    Marini Silvia
    Roberto Pozzi Mucelli
    Michele Tansella
    Paolo Brambilla
    Journal of Neural Transmission, 2011, 118 : 563 - 570
  • [33] MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis
    Villanueva-Meyer, Javier E.
    Wood, Matthew D.
    Choi, Byung Se
    Mabray, Marc C.
    Butowski, Nicholas A.
    Tihan, Tarik
    Cha, Soonmee
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 210 (03) : 621 - 628
  • [34] IMPACT OF GAP-43 AND ACTIN EXPRESSION ON THE OUTCOME AND OVERALL SURVIVAL IN DIFFUSE AND ANAPLASTIC GLIOMAS
    Krigers, Aleksandrs
    Demetz, Matthias
    Moser, Patrizia
    Kerschbaumer, Johannes
    Brawanski, Konstantin
    Fritsch, Helga
    Thome, Claudius
    Freyschlag, Christian
    NEURO-ONCOLOGY, 2022, 24 : 150 - 150
  • [35] Cell-Population Dynamics in Diffuse Gliomas during Gliomagenesis and Its Impact on Patient Survival
    Nikitin, Pavel V.
    Musina, Guzel R.
    Pekov, Stanislav I.
    Kuzin, Andrey A.
    Popov, Igor A.
    Belyaev, Artem Y.
    Kobyakov, Gregory L.
    Usachev, Dmitry Y.
    Nikolaev, Viktor N.
    Mikhailov, Valentin P.
    CANCERS, 2023, 15 (01)
  • [36] IMPACT OF GAP-43 AND ACTIN EXPRESSION ON THE OUTCOME AND OVERALL SURVIVAL IN DIFFUSE AND ANAPLASTIC GLIOMAS
    Krigers, A.
    Demetz, M.
    Moser, P.
    Kerschbaumer, J.
    Brawanski, K. R.
    Thome, C.
    Freyschlag, C. F.
    NEURO-ONCOLOGY, 2022, 24
  • [37] Radiomics Analysis of Quantitative Maps from Synthetic MRI for Predicting Grades and Molecular Subtypes of Diffuse Gliomas
    Lin, Danlin
    Liu, Jiehong
    Ke, Chao
    Chen, Haolin
    Li, Jing
    Xie, Yuanyao
    Ma, Jianhua
    Lv, Xiaofei
    Feng, Yanqiu
    CLINICAL NEURORADIOLOGY, 2024, 34 (04) : 817 - 826
  • [38] Dynamic contrast-enhanced MRI perfusion parameters are imaging biomarkers for angiogenesis in lung cancer
    Du, Yonghao
    Zhang, Shuo
    Liang, Ting
    Shang, Jin
    Guo, Chenguang
    Lian, Jie
    Gong, Huilin
    Yang, Jian
    Niu, Gang
    ACTA RADIOLOGICA, 2023, 64 (02) : 572 - 580
  • [39] Diffusion and perfusion imaging biomarkers of H3 K27M mutation status in diffuse midline gliomas
    Kathrani, Nihar
    Chauhan, Richa Singh
    Kotwal, Abhishek
    Kulanthaivelu, Karthik
    Bhat, Maya Dattatraya
    Saini, Jitender
    Prasad, Chandrajit
    Chakrabarti, Dhritiman
    Santosh, Vani
    Uppar, Alok Mohan
    Srinivas, Dwarakanath
    NEURORADIOLOGY, 2022, 64 (08) : 1519 - 1528
  • [40] Diffusion- and Perfusion-Weighted MRI Radiomics for Survival Prediction in Patients with Lower-Grade Gliomas
    Park, Chae Jung
    Kim, Sooyon
    Han, Kyunghwa
    Ahn, Sung Soo
    Kim, Dain
    Park, Yae Won
    Chang, Jong Hee
    Kim, Se Hoon
    Lee, Seung-Koo
    YONSEI MEDICAL JOURNAL, 2024, 65 (05) : 283 - 292